Novagali Pharma and Ardeo sign an exclusive distribution agreement for Nova23041

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

The Evolution of Self-Care: Where Vitauthority Fits in the Wellness Era

Over the past few decades, the concept of self-care...

Piramal Pharma Expands Lexington Sterile Injectables Plant

Piramal Pharma has started work on the expansion of...

China Unveils Innovative Drugs Policy to Boost Development

The National Health Commission and China's National Healthcare Security...

Ensuring optimal product integrity with pharmaceutical preservation strategies

Preserving the potency of pharmaceutical products is paramount in...

Novagali Pharma, a pharmaceutical company that develops innovative ophthalmic products, can today announce that it has signed an exclusive agreement with Ardeo Health, LLC for Nova23041 its unique formulation for thetreatment of dry eye symptoms in the United States and Canada with OCuSOFT, Inc. Nova23041 is a preservative-free oil-in-water emulsion resulting from Novasorb® patented technology whose
efficiency and tolerance in treating dry eye symptoms have been proven during a number of clinical trials carried out in Europe and Southeast Asia.

Based on the electrostatic attraction between the positively charged eye drop and the negatively charged ocular surface, Novasorb®’s technological platform enables the product to be spread in an optimal, uniform and comfortable way across the entire ocular surface, improves resilience time and thus reduces the number of instillations necessary with increased efficiency and optimal compliance and tolerance.

Latest stories

Related stories

The Evolution of Self-Care: Where Vitauthority Fits in the Wellness Era

Over the past few decades, the concept of self-care...

Piramal Pharma Expands Lexington Sterile Injectables Plant

Piramal Pharma has started work on the expansion of...

China Unveils Innovative Drugs Policy to Boost Development

The National Health Commission and China's National Healthcare Security...

Ensuring optimal product integrity with pharmaceutical preservation strategies

Preserving the potency of pharmaceutical products is paramount in...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back